American Regent introduces Nicardipine Hydrochloride Injection
SHIRLEY, N.Y. — American Regent announced the introduction of the only FDA approved USP standard Nicardipine Hydrochloride Injection. Nicardipine Hydrochloride is a calcium channel blocker indicated for the short-term treatment of hypertension when oral therapy is not feasible. “American Regent is pleased to be bringing back this shortage-prone product in a USP formulation, and to
